Micro-invasive Alternative to Lumpectomy

A new interstitial laser therapy (ILT) device ablates fibroadenomas (benign tumors) of the breast with tumor sizes ranging up to 20 mm in diameter.

The Novian ILT device is a micro-invasive technique that uses needle probes to deliver laser energy into the tumor, causing the tumor to shrink. ILT's major advantages over the traditional lumpectomy include access via two small needles rather than a scalpel wound; local anesthesia rather than general anesthesia or intravenous (IV) sedation; minimal post-operative scar tissue; reduced risk of surgical complication; and shorter preparation and quicker recovery time for patients. The ILT laser, a product of Novian Health (Chicago, IL, USA) has been approved by the U.S. Food and Drug Administration (FDA).

"Thousands of women in the U.S. find breast tumors each year, and about 80% of all breast tumors are benign,” said Dr. Kambiz Dowlat, a professor of Surgery at Rush University Medical Center and founder of Novian Health. "The traditional treatment for removing these tumors is a lumpectomy. Many women are hesitant to undergo this invasive surgery and, until now, that was really their only option. We believe that breast ILT provides women a better option to treat many tumors.”


Related Links:
Novian Health